柳叶刀 1990-2017年195个国家的全球、区域和国家的胰腺癌负担及其可归因的危险因素.pdfVIP

Articles The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 GBD 2017 Pancreatic Cancer Collaborators* Summary Lancet Gastroenterol Hepatol Background Worldwide, both the incidence and death rates of pancreatic cancer are increasing. Evaluation of 2019; 4: 934–47 pancreatic cancer burden and its global, regional, and national patterns is crucial to policy making and better resource Published Online allocation for controlling pancreatic cancer risk factors, developing early detection methods, and providing faster and October 21, 2019 more effective treatments. /10.1016/ S2468-1253(19)30347-4 This online publication has Methods Vital registration, vital registration sample, and cancer registry data were used to generate mortality, been corrected. The corrected incidence, and disability-adjusted life-years (DALYs) estimates. We used the comparative risk assessment framework version first appeared at to estimate the proportion of deaths attributable to risk factors for pancreatic cancer: smoking, high fasting plasma /gastrohep on glucose, and high body-mass index. All of the estimates were reported as counts and age-standardised rates per Feb 12, 2020 100 000 person-years. 95% uncertainty intervals (UIs) were reported for all estimates. See Comment page 895 *Collaborators listed at the end of the paper Findings In 2017, there were 448 000 (95% UI 439 000–456 000) incident cases